<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Exor N.v. — News on 6ix</title>
<link>https://6ix.com/company/exor-nv</link>
<description>Latest news and press releases for Exor N.v. on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Wed, 08 Apr 2026 15:51:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/exor-nv" rel="self" type="application/rss+xml" />
<item>
<title>Exor Press Release - Png and Della Chiesa Nominations</title>
<link>https://6ix.com/company/exor-nv/news/exor-press-release-png-and-della-chiesa-nominations-1</link>
<guid isPermaLink="true">https://6ix.com/company/exor-nv/news/exor-press-release-png-and-della-chiesa-nominations-1</guid>
<pubDate>Wed, 08 Apr 2026 15:51:00 GMT</pubDate>
<description>Amsterdam, 8 April 2026 EXOR NOMINATES TEMASEK CFO PNG CHIN YEE AND BENEDETTO DELLA CHIESA TO ITS BOARD Exor nominates Png Chin Yee and Benedetto Della Chiesa as non-executive members of its Board of Directors, subject to approval at the Company’s next Annual General Meeting on 20 May 2026. Ms. Png joined Temasek in July 2011 and was appointed President of Temasek Singapore on 1 April 2026, while continuing to serve as Chief Financial Officer, a role she has held since 1 January 2023. During her</description>
</item>
<item>
<title>Exor Press Release - FY2025 Results</title>
<link>https://6ix.com/company/exor-nv/news/exor-press-release-fy2025-results-1</link>
<guid isPermaLink="true">https://6ix.com/company/exor-nv/news/exor-press-release-fy2025-results-1</guid>
<pubDate>Mon, 23 Mar 2026 20:33:00 GMT</pubDate>
<description>Amsterdam, 23 March 2026 EXOR REPORTS €37.1 BILLION GROSS ASSET VALUE AT END-2025 NAV per share decreased by 8.1% compared to a 5.4% increase in the MSCI World IndexPerformance was driven by challenges at Exor’s largest companies, partially offset by a positive impact from the outstanding performance of Lingotto, the positive contribution from Iveco and unlisted companies and the share buybackLingotto reached over $10 billion of assets under management and delivered strong returns to Exor, mainl</description>
</item>
<item>
<title>Exor Press Release - 2026 Corporate Calendar</title>
<link>https://6ix.com/company/exor-nv/news/exor-press-release-2026-corporate-calendar</link>
<guid isPermaLink="true">https://6ix.com/company/exor-nv/news/exor-press-release-2026-corporate-calendar</guid>
<pubDate>Fri, 30 Jan 2026 10:00:00 GMT</pubDate>
<description>Amsterdam, 30 January 2026 EXOR PUBLISHES ITS 2026 CORPORATE CALENDAR Exor N.V. announced today the following corporate calendar for 2026: 23 March 2026: Publication of the financial statements for the full year 202524 March 2026: Investor & Analyst Call20 May 2026: Annual General Meeting of Shareholders22 September 2026: Publication of the interim financial statements for the half year 2026 The 2026 corporate calendar will be available on Exor’s website under the Corporate Calendar section. Any</description>
</item>
<item>
<title>RobCo Raises $100 Million to Scale Its Autonomous Industrial Robotics Platform</title>
<link>https://6ix.com/company/exor-nv/news/robco-raises-dollar100-million-to-scale-its-autonomous-industrial-robotics-platform</link>
<guid isPermaLink="true">https://6ix.com/company/exor-nv/news/robco-raises-dollar100-million-to-scale-its-autonomous-industrial-robotics-platform</guid>
<pubDate>Thu, 29 Jan 2026 13:00:00 GMT</pubDate>
<description>SAN FRANCISCO & MUNICH, January 29, 2026--RobCo, a physical AI-driven robotics company raised $100 million to advance RobCo’s Physical AI roadmap, expand enterprise deployments and deepen the company’s presence in the U.S. market.</description>
</item>
<item>
<title>Exor-Ferrari Family Press Release - Shareholders' Agreement</title>
<link>https://6ix.com/company/exor-nv/news/exor-ferrari-family-press-release-shareholders-agreement</link>
<guid isPermaLink="true">https://6ix.com/company/exor-nv/news/exor-ferrari-family-press-release-shareholders-agreement</guid>
<pubDate>Sat, 03 Jan 2026 17:47:00 GMT</pubDate>
<description>Amsterdam, 3 January 2026 EXOR AND THE FERRARI FAMILY EXTEND SHAREHOLDERS’ AGREEMENT ON FERRARI Exor N.V., on the one hand, and Piero Ferrari and Trust Piero Ferrari, on the other hand, have agreed to renew the shareholders’ agreement relating to Ferrari N.V., confirming their respective alignment and commitment to Ferrari. The new agreement enters into force upon expiration of the current shareholders’ agreement and will have a three-year term until 4 January 2029, with an automatic renewal for</description>
</item>
<item>
<title>Exor Press Release - Announcement on Juventus</title>
<link>https://6ix.com/company/exor-nv/news/exor-press-release-announcement-on-juventus</link>
<guid isPermaLink="true">https://6ix.com/company/exor-nv/news/exor-press-release-announcement-on-juventus</guid>
<pubDate>Sat, 13 Dec 2025 14:05:00 GMT</pubDate>
<description>Amsterdam, 13 December 2025 EXOR BOARD UNANIMOUSLY REJECTS TETHER’S PROPOSAL TO ACQUIRE EXOR’S CONTROLLING STAKE IN JUVENTUS Exor N.V. (“Exor” or the “Company”) announces that its Board of Directors has unanimously rejected an unsolicited proposal submitted by Tether Investments, S.A. de C.V. (“Tether”) to acquire all of the shares of Juventus Football Club S.p.A. (“Juventus” or the “Club”) owned by Exor. Exor reaffirms its previous, consistent statements that it has no intention of selling any</description>
</item>
<item>
<title>Lattice to Showcase Advanced Industrial and Edge AI Solutions at SPS 2025</title>
<link>https://6ix.com/company/exor-nv/news/lattice-to-showcase-advanced-industrial-and-edge-ai-solutions-at-sps-2025-1</link>
<guid isPermaLink="true">https://6ix.com/company/exor-nv/news/lattice-to-showcase-advanced-industrial-and-edge-ai-solutions-at-sps-2025-1</guid>
<pubDate>Tue, 11 Nov 2025 21:00:00 GMT</pubDate>
<description>HILLSBORO, Ore., November 11, 2025--Lattice Semiconductor (NASDAQ: LSCC), the low power programmable leader, today announced its participation in the upcoming SPS 2025, taking place on November 25 – 27, 2025 in Nuremberg, Germany.</description>
</item>
<item>
<title>Exor Press Release - Closing Announcement</title>
<link>https://6ix.com/company/exor-nv/news/exor-press-release-closing-announcement</link>
<guid isPermaLink="true">https://6ix.com/company/exor-nv/news/exor-press-release-closing-announcement</guid>
<pubDate>Wed, 05 Nov 2025 16:31:00 GMT</pubDate>
<description>Amsterdam, 5 November 2025 EXOR ANNOUNCES THE CLOSING OF ITS NOTES OFFERING Exor N.V. announces the settlement of the previously announced offering of €600 million notes priced on 29 October 2025 with a fixed annual coupon of 3.75% and due on 5 November 2035. The notes, rated A- by S&P Global Ratings, have been listed on the Luxembourg Stock Exchange and admitted to trading on the Euro MTF Market. This press release is not, and shall not contain or constitute, an offer to sell or a solicitation</description>
</item>
<item>
<title>Exor Press Release - Pricing Announcement</title>
<link>https://6ix.com/company/exor-nv/news/exor-press-release-pricing-announcement</link>
<guid isPermaLink="true">https://6ix.com/company/exor-nv/news/exor-press-release-pricing-announcement</guid>
<pubDate>Wed, 29 Oct 2025 16:48:00 GMT</pubDate>
<description>Amsterdam, 29 October 2025 EXOR ANNOUNCES THE PRICING OF €600 MILLION NOTES MATURING IN 2035 Exor N.V. (rated A– with a stable outlook by Standard & Poor’s) announces that it has priced €600 million notes due 5 November 2035 carrying a fixed annual coupon of 3.75%, with an issue price of 99.386%. The purpose of the issue is to raise new funds for Exor’s general corporate purposes, including refinancing of existing debt. The notes will be listed on the Luxembourg Stock Exchange, admitted to tradi</description>
</item>
<item>
<title>Aerska Launches with $21 Million in Financing to Develop RNAi Medicines for Diseases of the Brain</title>
<link>https://6ix.com/company/exor-nv/news/aerska-launches-with-dollar21-million-in-financing-to-develop-rnai-medicines-for-diseases-of-the-brain</link>
<guid isPermaLink="true">https://6ix.com/company/exor-nv/news/aerska-launches-with-dollar21-million-in-financing-to-develop-rnai-medicines-for-diseases-of-the-brain</guid>
<pubDate>Wed, 01 Oct 2025 11:00:00 GMT</pubDate>
<description>Seasoned RNAi and CNS leaders come together to build a pipeline of systemically administered RNA medicines using advances in ‘brain shuttles’ DUBLIN and LONDON, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Aerska, a biotechnology company aiming to redefine the treatment of neurological diseases, today announced it has raised $21 million in seed financing, co-led by Age1, Backed VC and Speedinvest, with participation from Blueyard, Lingotto (Exor), Norrsken VC, Kerna, PsyMed, Saras, and Ada Ventures. The co</description>
</item>
<item>
<title>Exor Press Release - H1 2025 Results</title>
<link>https://6ix.com/company/exor-nv/news/exor-press-release-h1-2025-results</link>
<guid isPermaLink="true">https://6ix.com/company/exor-nv/news/exor-press-release-h1-2025-results</guid>
<pubDate>Wed, 17 Sep 2025 15:35:00 GMT</pubDate>
<description>Amsterdam, 17 September 2025 EXOR NAV PER SHARE OUTPERFORMS MSCI WORLD INDEX In the first half of 2025, Exor’s net asset value (NAV) per share outperformed the MSCI World Index by 5 percentage points, supported by €1 billion share buybackDespite significant market volatility, Companies performed in line with the MSCI World Index with varied performance across holdingsLingotto delivered strong returns of 11% over the period, mainly driven by its public investmentsExor is well-positioned to seize</description>
</item>
<item>
<title>Investlinx Expands to Germany and Austria with Two Unique High-Conviction ETFs</title>
<link>https://6ix.com/company/exor-nv/news/investlinx-expands-to-germany-and-austria-with-two-unique-high-conviction-etfs</link>
<guid isPermaLink="true">https://6ix.com/company/exor-nv/news/investlinx-expands-to-germany-and-austria-with-two-unique-high-conviction-etfs</guid>
<pubDate>Thu, 11 Sep 2025 09:56:00 GMT</pubDate>
<description>FRANKFURT AM MAIN, Germany, September 11, 2025--Investlinx lists two actively managed ETFs on Xetra, expanding to Germany and Austria with high-conviction strategies.</description>
</item>
<item>
<title>Exor Press Release - 2025 AGM</title>
<link>https://6ix.com/company/exor-nv/news/exor-press-release-2025-agm</link>
<guid isPermaLink="true">https://6ix.com/company/exor-nv/news/exor-press-release-2025-agm</guid>
<pubDate>Thu, 22 May 2025 14:11:00 GMT</pubDate>
<description>Amsterdam, 22 May 2025 EXOR SHAREHOLDERS APPROVE ALL RESOLUTIONS AT AGM Exor N.V. (“Exor” or the “Company”) shareholders approved all resolutions proposed by the Board of Directors at the Annual General Meeting (the “AGM”) held today in Amsterdam. The AGM adopted Exor’s 2024 annual accounts and approved a dividend distribution of €0.49 per outstanding share, for a total of approximately €100 million. The dividend will become payable on 28 May 2025, with an ex-dividend date of 26 May 2025, and wi</description>
</item>
<item>
<title>Exor Press Release - Tender Offer Result</title>
<link>https://6ix.com/company/exor-nv/news/exor-press-release-tender-offer-result</link>
<guid isPermaLink="true">https://6ix.com/company/exor-nv/news/exor-press-release-tender-offer-result</guid>
<pubDate>Thu, 24 Apr 2025 05:45:00 GMT</pubDate>
<description>THIS PRESS RELEASE IS NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO, OR TO ANY PERSON LOCATED OR RESIDENT IN AUSTRALIA, CANADA, JAPAN, OR ANY OTHER JURISDICTION IN WHICH SUCH DISTRIBUTION WOULD BE PROHIBITED BY APPLICABLE LAW. Amsterdam, 24 April 2025 EXOR ANNOUNCES OVERSUBSCRIBED TENDER OFFER, AS PART OF €1 BILLION SHARE BUYBACK PROGRAM Exor N.V. (“Exor” or the “Company”) announces the results of the Tender Offer set out in the Offer Memorandum published by th</description>
</item>
<item>
<title>Exor Press Release - Announcement of the Reference VWAP for the Tender Offer</title>
<link>https://6ix.com/company/exor-nv/news/exor-press-release-announcement-of-the-reference-vwap-for-the-tender-offer</link>
<guid isPermaLink="true">https://6ix.com/company/exor-nv/news/exor-press-release-announcement-of-the-reference-vwap-for-the-tender-offer</guid>
<pubDate>Thu, 17 Apr 2025 16:23:00 GMT</pubDate>
<description>THIS PRESS RELEASE IS NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO, OR TO ANY PERSON LOCATED OR RESIDENT IN AUSTRALIA, CANADA, JAPAN, OR ANY OTHER JURISDICTION IN WHICH SUCH DISTRIBUTION WOULD BE PROHIBITED BY APPLICABLE LAW. Amsterdam, 17 April 2025 EXOR N.V.: ANNOUNCEMENT OF THE REFERENCE VWAP FOR THE TENDER OFFER On 17 April 2025, the reported closing price of the Ordinary Shares on Euronext Amsterdam was EUR 78.30 per Ordinary Share. The volume weighted av</description>
</item>
<item>
<title>Exor Press Release - Karl Guha Nomination</title>
<link>https://6ix.com/company/exor-nv/news/exor-press-release-karl-guha-nomination</link>
<guid isPermaLink="true">https://6ix.com/company/exor-nv/news/exor-press-release-karl-guha-nomination</guid>
<pubDate>Thu, 10 Apr 2025 13:30:00 GMT</pubDate>
<description>Amsterdam, 10 April 2025 ING CHAIRMAN KARL GUHA NOMINATED TO JOIN EXOR BOARD Exor nominates ING Chairman Karl Guha as a non-executive member of its Board of Directors, subject to approval at the Company’s next Annual General Meeting on 22 May 2025. Karl is an international banker with over three decades of experience across the United States, Europe, Australia and Asia. He began his career at ABN Amro in 1989, holding various executive roles. He then served as Group Chief Risk Officer of Unicred</description>
</item>
<item>
<title>Exor Press Release - Tender Offer Launch</title>
<link>https://6ix.com/company/exor-nv/news/exor-press-release-tender-offer-launch</link>
<guid isPermaLink="true">https://6ix.com/company/exor-nv/news/exor-press-release-tender-offer-launch</guid>
<pubDate>Wed, 26 Mar 2025 18:00:00 GMT</pubDate>
<description>THIS PRESS RELEASE IS NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO, OR TO ANY PERSON LOCATED OR RESIDENT IN AUSTRALIA, CANADA, JAPAN, OR ANY OTHER JURISDICTION IN WHICH SUCH DISTRIBUTION WOULD BE PROHIBITED BY APPLICABLE LAW. Amsterdam, 26 March 2025 EXOR ANNOUNCES THE LAUNCH OF A TENDER OFFER TO REPURCHASE UP TO €1 BILLION IN ORDINARY SHARES Exor N.V. (“Exor” or the “Company”) announces the launch of a tender offer to purchase ordinary shares with a nominal v</description>
</item>
<item>
<title>Exor Press Release - FY24 Results</title>
<link>https://6ix.com/company/exor-nv/news/exor-press-release-fy24-results</link>
<guid isPermaLink="true">https://6ix.com/company/exor-nv/news/exor-press-release-fy24-results</guid>
<pubDate>Wed, 26 Mar 2025 17:10:00 GMT</pubDate>
<description>Amsterdam, 26 March 2025 EXOR DELIVERS 9% NAV PER SHARE GROWTH IN 2024 LAUNCH OF A €1 BILLION SHARE BUYBACK PROGRAM WITH TENDER OFFER AT UP TO 10% PREMIUM NAV reached €38.2 billion at 31 December 2024, with NAV per share increasing by 9%Strong cash flow generation with dividends received from companies and asset disposals amounting to €1.5 billion in 2024. Active and disciplined capital allocation with increased exposure to Healthcare Ordinary dividend to be distributed of approximately €100 mil</description>
</item>
<item>
<title>Correction: Exor Press Release - ABO Pricing</title>
<link>https://6ix.com/company/exor-nv/news/correction-exor-press-release-abo-pricing</link>
<guid isPermaLink="true">https://6ix.com/company/exor-nv/news/correction-exor-press-release-abo-pricing</guid>
<pubDate>Thu, 27 Feb 2025 06:34:00 GMT</pubDate>
<description>Amsterdam, 27 February 2025 EXOR ANNOUNCES THE SUCCESSFUL PRICING OF THE ACCELERATED BOOKBUILD OFFERING FOR APPROXIMATELY 4% OF FERRARI’S OUTSTANDING SHARES Exor N.V. (“Exor”) announces the successful pricing of the previously announced accelerated bookbuild offering involving the sale of approximately 7 million common shares of Ferrari N.V. (“Ferrari”) (representing approximately 4% of the outstanding common shares of Ferrari) to institutional investors (the “Offering”) for total proceeds of €3</description>
</item>
<item>
<title>Exor Press Release - ABO Launch</title>
<link>https://6ix.com/company/exor-nv/news/exor-press-release-abo-launch</link>
<guid isPermaLink="true">https://6ix.com/company/exor-nv/news/exor-press-release-abo-launch</guid>
<pubDate>Thu, 27 Feb 2025 06:30:00 GMT</pubDate>
<description>Amsterdam, 27 February 2025 EXOR ANNOUNCES THE SUCCESSFUL PRICING OF THE ACCELERATED BOOKBUILD OFFERING FOR APPROXIMATELY 4% OF FERRARI’S OUTSTANDING SHARES Exor N.V. (“Exor”) announces the successful pricing of the previously announced accelerated bookbuild offering involving the sale of approximately 7 million common shares of Ferrari N.V. (“Ferrari”) (representing approximately 4% of the outstanding common shares of Ferrari) to institutional investors (the “Offering”) for total proceeds of €3</description>
</item>
</channel>
</rss>